Encube Ethicals Ltd

·
IPO
Open Date
TBA
Close Date
TBA
Listing Date
Allotment Date
Current Price
—
High / Low
₹— / ₹—
ROCE
32.30 %
ROE
25.65 %
Face Value
₹1
About
Incorporated in September 1995, Encube Ethicals Limited is a global pharmaceutical formulations company specializing in topical and transdermal dosage forms, serving 50 countries, including regulated markets such as the …
📍 803, B Wing HDIL Kaledonia, Sahar Road Andheri East Mumbai, Maharashtra, 400069
📞 22 62288000
✉️ compliance.cs@encubeethicals.com

Encube Ethicals Ltd IPO About the Company

Incorporated in September 1995, Encube Ethicals Limited is a global pharmaceutical formulations company specializing in topical and transdermal dosage forms, serving 50 countries, including regulated markets such as the United States, the UK, Europe, and India. The company operates through three integrated business verticals: Global Generics, Global CDMO (Contract Development and Manufacturing Organization), and India Branded Formulations, providing end-to-end capabilities across research & development, formulation development, manufacturing, regulatory compliance, and commercialization. It is one of the fastest-growing players in the US topical generics market and has a strong presence in regulated international markets.Encube operates large-scale regulatory-approved manufacturing facilities supported by advanced R&D infrastructure, a robust innovation pipeline, and long-standing relationships with leading global pharmaceutical companies. The company also markets branded topical products in India through an established distribution network.Encube focuses on innovation, quality, regulatory compliance, and customer-centric product development.As of March 31, 2026, the company had 1,695 permanent employees and 982 factory workers across production, R&D, quality, supply chain, finance, IT, and commercial functions.StrengthsLarge-scale regulatory-approved manufacturing with a strong compliance record.Strong R&D capabilities driving innovation and product pipeline.Integrated business model across Global Generics, CDMO, and India Branded Formulations.Fast-growing presence in the US topical generics market and strong global customer relationships.Experienced leadership team with a proven track record of business growth and transformation.

Encube Ethicals Ltd IPO Analysis

Pros

  • ROE of 25.65% indicates good return on equity.
  • ROCE of 32.30% shows efficient capital usage.
  • PAT margin of 23.62%.

Cons

  • Detailed analysis available after listing.

Pros and cons are machine generated. Please exercise caution and do your own analysis.

Encube Ethicals Ltd IPO Subscription Status

Consolidated figures
MetricQIBNII (HNI)RetailTotal
Subscription — — — —
Shares Not more than 50% of the Offer Not less than 15% of the Offer Not less than 35% of the Offer —
Bids — — — —
▼ Category-wise Detailed Breakdown
CategorySubscriptionOffered Bid SharesAmt (₹ Cr)
QIB - Not more than 50% of the Offer — —
NII (HNI) - Not less than 15% of the Offer — —
Retail - Not less than 35% of the Offer — —
Market Maker 1.00×
— — —
Total - 100 — —
Applications: -

Encube Ethicals Ltd IPO Profit & Loss

Figures in ₹ Crores / Amount in ₹ Crore
Metric 31 Mar 202631 Mar 202531 Mar 2024
Revenue 1,911.80 1,369.00 1,098.20
EBITDA 663.30 452.10 297.60
Profit After Tax 436.70 249.60 156.10
Net Worth 1,953.60 1,512.80 1,258.40
Total Assets 2,792.10 2,300.10 1,871.80
Reserves 1,915.20 1,495.20 1,243.40
Borrowings 221.70 230.50 228.10
Sales Growth
3 Years:-42.6%
Latest:1,098.20 Cr
Profit Growth
3 Years:-64.3%
Latest PAT:156.10 Cr
Return on Equity
ROE:25.65%
ROCE:32.30%

Encube Ethicals Ltd IPO Key Financial Ratios

Profitability
ROE 25.65%
ROCE 32.30%
RONW 25.21%
PAT Margin 23.62%
EBITDA Margin 35.88%
Valuation
Pre EPS 14.37
Post EPS 14.37
Leverage & Growth
Debt / Equity 0.13×
Sales Growth (3yr) -42.6%
Profit Growth (3yr) -64.3%
Latest Revenue 1,098.20 Cr
Latest PAT 156.10 Cr

Encube Ethicals Ltd IPO Schedule & Important Dates

IPO Open
TBA
Upcoming
IPO Close
TBA
Upcoming

Encube Ethicals Ltd IPO Lot Size & Investment Details

Category Lots Shares Amount (₹)
Retail (Min) — — —
Pre-Issue Holding: 30,38,84,790 shares Post-Issue Holding: 30,38,84,790 shares

Encube Ethicals Ltd IPO Lead Managers & Market Makers

Book Running Lead Managers
JM Financial Ltd Axis Capital Ltd Kotak Mahindra Capital Co.Ltd

Encube Ethicals Ltd IPO Allotment Status

Registrar: MUFG Intime India Pvt.Ltd
Check Allotment
022-49186000
encubeethicals.ipo@in.mpms.mufg.com
https://in.mpms.mufg.com/Initial_Offer/public-issues.html